Ho V - Search Results

1

Efalizumab, a reversible T-cell modulator for psoriasis.

Shear NH, Langley RG, Ho V. Shear NH, et al. Among authors: ho v. J Cutan Med Surg. 2006;9 Suppl 1:4-9. doi: 10.1007/s10227-006-0101-3. J Cutan Med Surg. 2006. PMID: 16633862 Review.

2

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. Among authors: ho v. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

3

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis.

Papp KA, Ho V, Langley R, Lynde C, Poulin Y, Shear N, Toole J, Zip C. Papp KA, et al. Among authors: ho v. J Cutan Med Surg. 2006;9 Suppl 1:26-32. doi: 10.1007/s10227-006-0104-0. J Cutan Med Surg. 2006. PMID: 16633859 Review.

4

Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches.

Langley RG, Ho V, Lynde C, Papp KA, Poulin Y, Shear N, Toole J, Zip C. Langley RG, et al. Among authors: ho v. J Cutan Med Surg. 2006;9 Suppl 1:18-25. doi: 10.1007/s10227-006-0103-1. J Cutan Med Surg. 2006. PMID: 16633860 Review.

5

Safety of conventional systemic agents and biologic agents in the treatment of psoriasis.

Bissonnette R, Ho V, Langley RG. Bissonnette R, et al. Among authors: ho v. J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2:S67-76. doi: 10.2310/7750.2009.00023. J Cutan Med Surg. 2009. PMID: 19799829 Review.

6

Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology.

Mydlarski PR, Ho V, Shear NH. Mydlarski PR, et al. Among authors: ho v. J Cutan Med Surg. 2006 Sep-Oct;10(5):205-21. doi: 10.2310/7750.2006.00048. J Cutan Med Surg. 2006. PMID: 17234104

7

Chan B, Hales B, Shear N, Ho V, Lynde C, Poulin Y, Mittmann N. Chan B, et al. Among authors: ho v. J Cutan Med Surg. 2009 Jul-Aug;13(4):192-7. doi: 10.2310/7750.2009.08068. J Cutan Med Surg. 2009. PMID: 19706226

8

Canadian practical guide for the treatment and management of atopic dermatitis.

Lynde C, Barber K, Claveau J, Gratton D, Ho V, Krafchik B, Langley R, Marcoux D, Murray E, Shear N. Lynde C, et al. Among authors: ho v. J Cutan Med Surg. 2005;8 Suppl 5:1-9. doi: 10.1007/s10227-005-8080-3. J Cutan Med Surg. 2005. PMID: 19830906 Review.

9

Canadian hand dermatitis management guidelines.

Lynde C, Guenther L, Diepgen TL, Sasseville D, Poulin Y, Gulliver W, Agner T, Barber K, Bissonnette R, Ho V, Shear NH, Toole J. Lynde C, et al. Among authors: ho v. J Cutan Med Surg. 2010 Nov-Dec;14(6):267-84. doi: 10.2310/7750.2010.09094. J Cutan Med Surg. 2010. PMID: 21084020 Review.

10

Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.

Brodmerkel C, Wadman E, Langley RG, Papp KA, Bourcier M, Poulin Y, Ho V, Guenther L, Kunynetz R, Nigen S, Vender R, Wasel N, Hsu MC, Szapary P. Brodmerkel C, et al. Among authors: ho v. J Drugs Dermatol. 2013 Oct;12(10):1122-9. J Drugs Dermatol. 2013. PMID: 24085047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,438 results

Search Page

Filters